Practice – Civil litigation. The Queen's Bench Division gave directions in the claimants' case in which it had been alleged that the defendant's drug was worse than other drugs of a similar nature in relation to symptoms following discontinuation of its use such that the drug was 'defective' within s 3 of the Consumer Protection Act 1987. It was not appropriate to bring the process to an end under the court's case management powers at the present stage.